BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17060384)

  • 1. Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Rajagopalan S; Dellegrottaglie S; Furniss AL; Gillespie BW; Satayathum S; Lameire N; Saito A; Akiba T; Jadoul M; Ginsberg N; Keen M; Port FK; Mukherjee D; Saran R
    Circulation; 2006 Oct; 114(18):1914-22. PubMed ID: 17060384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral arterial disease in patients with stages IV and V chronic renal failure.
    Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A
    Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients.
    Jaar BG; Plantinga LC; Astor BC; Fink NE; Longenecker C; Tracy RP; Marcovina SM; Powe NR; Coresh J
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):304-13. PubMed ID: 17603986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Lopes AA; Bragg-Gresham JL; Satayathum S; McCullough K; Pifer T; Goodkin DA; Mapes DL; Young EW; Wolfe RA; Held PJ; Port FK;
    Am J Kidney Dis; 2003 Mar; 41(3):605-15. PubMed ID: 12612984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Ethier J; Bragg-Gresham JL; Piera L; Akizawa T; Asano Y; Mason N; Gillespie BW; Young EW
    Am J Kidney Dis; 2007 Oct; 50(4):602-11. PubMed ID: 17900460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study.
    Liu T; Liang KV; Rosenbaum A; Stephenson R; Pike F; Weissfeld L; Unruh ML
    Nephrol Dial Transplant; 2012 Jul; 27(7):2929-36. PubMed ID: 22273665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
    Regensteiner JG; Hiatt WR; Coll JR; Criqui MH; Treat-Jacobson D; McDermott MM; Hirsch AT
    Vasc Med; 2008 Feb; 13(1):15-24. PubMed ID: 18372434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Moist LM; Bragg-Gresham JL; Pisoni RL; Saran R; Akiba T; Jacobson SH; Fukuhara S; Mapes DL; Rayner HC; Saito A; Port FK
    Am J Kidney Dis; 2008 Apr; 51(4):641-50. PubMed ID: 18371540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bradbury BD; Fissell RB; Albert JM; Anthony MS; Critchlow CW; Pisoni RL; Port FK; Gillespie BW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):89-99. PubMed ID: 17699392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).
    Bragg-Gresham JL; Fissell RB; Mason NA; Bailie GR; Gillespie BW; Wizemann V; Cruz JM; Akiba T; Kurokawa K; Ramirez S; Young EW
    Am J Kidney Dis; 2007 Mar; 49(3):426-31. PubMed ID: 17336704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life among haemodialysis patients--relationship with clinical indicators, morbidity and mortality.
    Morsch CM; Gonçalves LF; Barros E
    J Clin Nurs; 2006 Apr; 15(4):498-504. PubMed ID: 16553764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study.
    Ng YH; Meyer KB; Kusek JW; Yan G; Rocco MV; Kimmel PL; Benz RL; Beddhu S; Dwyer JT; Toto RD; Eknoyan G; Unruh ML
    Am J Kidney Dis; 2006 Apr; 47(4):614-24. PubMed ID: 16564939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients.
    Rahmanian PB; Adams DH; Castillo JG; Vassalotti J; Filsoufi F
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):915-22. PubMed ID: 18374780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.